Biotech intelligence organized for investors
Track what biotech companies do, not what they say. Get trial changes, enrollment updates, SEC filings, and market performance in one place.
Market Movers
Stock price movements, volume spikes, and options activity for biotech companies.
Market data as of Dec 30, 2025
Updated daily after market close
Biggest 7-Day Price Moves
Companies with the largest percentage changes over the past week
| Company | Price | Market Cap | 3-Day | 7-Day | Volume | Pipeline | Recent Event |
|---|---|---|---|---|---|---|---|
|
OMER
|
$16.96 | $1.2B | +8.0% | +93.8% | 4.2M |
3 P2
Next: Dec 31
|
🎯 Results Posted
8-K
|
|
OMEROS CORP
OMER
$16.96
•
7d: +93.8%
•
3d: +8.0%
Cap: $1.2B
•
Vol: 4.2M
3 P2
Next: Dec 31
🎯 Results Posted
8-K
|
|||||||
| $21.92 | $304M | +6.0% | +50.4% | 1.5M | No active P2/P3 |
8-K
|
|
|
LPCN
|
$6.57 | $36M | +25.6% | +42.5% | 198K |
1 P3
|
upcoming_completion
SCHEDULE 13G
|
|
Lipocine Inc.
LPCN
$6.57
•
7d: +42.5%
•
3d: +25.6%
Cap: $36M
•
Vol: 198K
1 P3
upcoming_completion
SCHEDULE 13G
|
|||||||
| $15.37 | $1.8B | -0.1% | +38.1% | 4.3M |
2 P2
|
upcoming_completion
8-K
|
|
|
$15.37
•
7d: +38.1%
•
3d: -0.1%
Cap: $1.8B
•
Vol: 4.3M
2 P2
upcoming_completion
8-K
|
|||||||
| $22.78 | $2.2B | -33.4% | -33.3% | 11.0M | No active P2/P3 |
8-K
Clinical
|
|
|
$22.78
•
7d: -33.3%
•
3d: -33.4%
Cap: $2.2B
•
Vol: 11.0M
8-K
Clinical
|
|||||||
|
INAB
|
$2.33 | $23M | +4.5% | +33.1% | 228K |
1 P2
Next: Dec 31
|
upcoming_completion
SCHEDULE 13G
|
|
IN8BIO, INC.
INAB
$2.33
•
7d: +33.1%
•
3d: +4.5%
Cap: $23M
•
Vol: 228K
1 P2
Next: Dec 31
upcoming_completion
SCHEDULE 13G
|
|||||||
| $2.84 | $179M | +15.9% | +29.7% | 528K | No active P2/P3 |
EFFECT
|
|
|
HCWB
|
$1.13 | $3M | -20.1% | -27.2% | 164K | No active P2/P3 | — |
|
USAQ
|
$0.55 | $6M | +33.0% | +27.0% | 16K | No active P2/P3 |
8-K
|
| $0.60 | $26M | +5.7% | +25.5% | 45K | No active P2/P3 |
8-K
|
|
| $0.30 | $28M | -6.9% | +24.2% | 2.0M | No active P2/P3 |
8-K
Licensing
|
|
|
ZURA
|
$5.32 | $346M | +14.4% | +23.4% | 670K | No active P2/P3 |
8-K
|
|
ISPC
|
$0.30 | $3M | -22.6% | -22.2% | 1.2M | No active P2/P3 |
EFFECT
|
|
PEPG
|
$6.42 | $441M | +10.5% | +20.2% | 547K | No active P2/P3 | — |
| $1.97 | $524M | +18.0% | +20.1% | 3.8M | No active P2/P3 | — | |
| $3.31 | $488M | +15.3% | +19.5% | 22.8M |
1 P3
1 P2
Next: Dec 31
|
upcoming_completion
|
|
|
$3.31
•
7d: +19.5%
•
3d: +15.3%
Cap: $488M
•
Vol: 22.8M
1 P3
1 P2
Next: Dec 31
upcoming_completion
|
|||||||
| $2.58 | $111M | +0.4% | +18.9% | 827K | No active P2/P3 |
8-K
Licensing
|
|
|
$2.58
•
7d: +18.9%
•
3d: +0.4%
Cap: $111M
•
Vol: 827K
8-K
Licensing
|
|||||||
| $0.67 | $160M | -10.1% | -18.6% | 567K |
1 P2
Next: Mar 15
|
upcoming_completion
|
|
|
$0.67
•
7d: -18.6%
•
3d: -10.1%
Cap: $160M
•
Vol: 567K
1 P2
Next: Mar 15
upcoming_completion
|
|||||||
| $1.76 | $121M | -23.1% | -18.1% | 2.3M | No active P2/P3 |
8-K
FDA
|
|
|
$1.76
•
7d: -18.1%
•
3d: -23.1%
Cap: $121M
•
Vol: 2.3M
8-K
FDA
|
|||||||
| $0.93 | $3M | -15.9% | -17.4% | 317K | No active P2/P3 | — | |
| $1.30 | $119M | +15.0% | +17.1% | 649K | No active P2/P3 | — | |
|
IOBT
|
$0.58 | $42M | -21.4% | -17.0% | 1.2M | No active P2/P3 |
8-K
|
| $0.71 | $21M | -11.3% | -15.5% | 254K | No active P2/P3 | — | |
| $31.59 | $671M | -10.0% | -15.4% | 140K | No active P2/P3 |
424B5
|
|
|
MTSR
|
$70.50 | $7.4B | -15.2% | -15.2% | 0 |
5 P2
Next: Dec 31
|
upcoming_completion
|
|
Metsera, Inc.
MTSR
$70.50
•
7d: -15.2%
•
3d: -15.2%
Cap: $7.4B
•
Vol: 0
5 P2
Next: Dec 31
upcoming_completion
|
|||||||
| $6.36 | $0 | -9.7% | -14.7% | 220K | No active P2/P3 | — | |
| $36.58 | $2.0B | -13.9% | -14.6% | 306K |
3 P3
2 P2
|
upcoming_completion
|
|
|
$36.58
•
7d: -14.6%
•
3d: -13.9%
Cap: $2.0B
•
Vol: 306K
3 P3
2 P2
upcoming_completion
|
|||||||
| $6.44 | $6M | -7.5% | -14.5% | 12K | No active P2/P3 |
8-K
|
|
| $0.73 | $23M | -9.1% | -14.5% | 757K | No active P2/P3 |
8-K
|
|
| $2.37 | $7M | -6.0% | -14.4% | 170K | No active P2/P3 |
8-K
|
|
| $0.75 | $4M | -12.9% | -14.4% | 87K | No active P2/P3 | — | |
| $70.19 | $7.4B | -15.1% | -14.4% | 2.4M |
1 P3
4 P2
Next: Dec 31
|
upcoming_completion
|
|
|
$70.19
•
7d: -14.4%
•
3d: -15.1%
Cap: $7.4B
•
Vol: 2.4M
1 P3
4 P2
Next: Dec 31
upcoming_completion
|
|||||||
|
NUWE
|
$1.76 | $2M | -13.7% | -14.1% | 26K | No active P2/P3 | — |
| $6.99 | $15M | -8.7% | -14.0% | 18K | No active P2/P3 |
8-K
|
|
|
BIVI
|
$1.13 | $9M | -6.6% | -13.7% | 353K | No active P2/P3 | — |
|
ALMS
|
$9.88 | $1.0B | -9.9% | -13.7% | 808K | No active P2/P3 | — |
|
ENTX
|
$2.00 | $92M | +16.3% | +13.6% | 184K |
1 P2
|
upcoming_completion
|
|
Entera Bio Ltd.
ENTX
$2.00
•
7d: +13.6%
•
3d: +16.3%
Cap: $92M
•
Vol: 184K
1 P2
upcoming_completion
|
|||||||
| $1.03 | $58M | -2.8% | +13.1% | 624K | No active P2/P3 | — | |
| $24.54 | $2.6B | -6.9% | +12.9% | 911K |
5 P2
|
upcoming_completion
|
|
|
$24.54
•
7d: +12.9%
•
3d: -6.9%
Cap: $2.6B
•
Vol: 911K
5 P2
upcoming_completion
|
|||||||
|
LTRN
|
$3.06 | $34M | -12.1% | -12.6% | 82K |
2 P2
Next: Dec 31
|
upcoming_completion
|
|
Lantern Pharma Inc.
LTRN
$3.06
•
7d: -12.6%
•
3d: -12.1%
Cap: $34M
•
Vol: 82K
2 P2
Next: Dec 31
upcoming_completion
|
|||||||
| $11.67 | $99M | +1.6% | +12.4% | 144K | No active P2/P3 |
8-K
|
|
| $5.46 | $3M | -11.5% | -12.4% | 21K |
1 P2
Next: Feb 1
|
upcoming_completion
8-K
|
|
|
$5.46
•
7d: -12.4%
•
3d: -11.5%
Cap: $3M
•
Vol: 21K
1 P2
Next: Feb 1
upcoming_completion
8-K
|
|||||||
|
NSPR
|
$1.89 | $80M | -3.1% | -12.1% | 31K | No active P2/P3 |
8-K
|
| $1.53 | $33M | -7.8% | -11.6% | 585K | No active P2/P3 | — | |
|
OWLT
|
$16.03 | $443M | +3.2% | +11.3% | 264K | No active P2/P3 | — |
| $27.33 | $1.6B | -2.5% | +11.1% | 980K |
5 P3
4 P2
|
upcoming_completion
|
|
|
$27.33
•
7d: +11.1%
•
3d: -2.5%
Cap: $1.6B
•
Vol: 980K
5 P3
4 P2
upcoming_completion
|
|||||||
|
BHVN
|
$11.64 | $1.5B | +4.4% | +10.9% | 2.3M |
9 P3
10 P2
|
upcoming_completion
|
|
Biohaven Ltd.
BHVN
$11.64
•
7d: +10.9%
•
3d: +4.4%
Cap: $1.5B
•
Vol: 2.3M
9 P3
10 P2
upcoming_completion
|
|||||||
| $5.51 | $225M | -8.5% | -10.8% | 774K | No active P2/P3 | — | |
|
HUMA
|
$1.01 | $189M | -5.6% | -10.6% | 6.4M | No active P2/P3 |
8-K
|
|
RLYB
|
$0.68 | $29M | -1.4% | -10.2% | 145K | No active P2/P3 | — |